Sonrotoclax TFA

• Target:

  Bcl-2 Family

• Related Pathways:

  Apoptosis

• Purity:

  >99.99%

• Bioactivity:

  Sonrotoclax TFA is an orally available and highly potent and selective Bcl-2 inhibitor of WT and G101V mutants with antitumor activity for the study of hematologic malignancies.

• Smiles:

  CC (C1=C (C=CC=C1) [C@H]2N (CCC2) C3CC4 (CCN (C5=CC (OC6=CN=C (NC=C7) C7=C6) =C (C=C5) C (NS (=O) (C8=CC (N (=O) =O) =C (C=C8) NC[C@@H]9CC[C@@] (O) (CC9) C) =O) =O) CC4) C3) C.OC (C (F) (F) F) =O

• Molecular Formula:

  C51H60F3N7O9S

• Molecular Weight:

  1004.12

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C